Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)

DBCAT004505Pharmacologic class

A DrugBank category of 154 drugs. 125 of them are approved.

Part of: Cytochrome P-450 CYP2D6 Inhibitors
Also known as: Unclassified CYP2D6 Inhibitors
Drugs: (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Abemaciclib
Acebutolol
Adagrasib
Amodiaquine
Amoxapine
Artenimol
Atorvastatin
Azelastine
Belumosudil
Bepridil
Berberine
Bicalutamide
Biperiden
Black cohosh
Brincidofovir
Camizestrant
Cannabidiol
Cannabinol
Celecoxib
Cerivastatin
Chamazulene
Chlorpheniramine
Chlorpromazine
and 129 more with a free account

What you can answer from here — as of May 20, 2021

154DrugsEach linked to its full drug card

580Drug targetsEvery drug–target pair in the class, with bond type

44,946Marketed productsAcross the regions we cover, with dosage forms and routes

59Routes of administrationHow the drugs in this class are given

Which targets do Cytochrome P-450 CYP2D6 Inhibitors (strength unknown) share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.